Pfizer’s $10B Obesity Deal Shows New Pharma Reality
Pfizer just won a heated $10 billion bidding war for biotech Metsera against Novo Nordisk, but the real story is how U.S. regulators intervened. The FTC’s unusual speed in blocking Novo’s bid while fast-tracking Pfizer’s signals a new era for pharma deals. This isn’t just business as usual – it’s po